3D Printed Drugs Market Trends

Growth Drivers

• Rising Prevalence Of Diseases Among Children Such As Pneumonia -For instance, approximately 2,000 children are killed by pneumonia every day, which is more than any other infectious disease. More than 200,000 of them are newborns.Taking medication could therefore become much easier for children who are resistant to taking the medication they need owing to 3D printed drugs. The first benefit of these tablets is that they may be able to choose the shape, color and design of the tablet, as well as its taste. The increasing number of diseases among children are contributing to the increased adoption of these drugs, which is anticipated to drive global drugs market over the forecast period.
• Increase In Research And Development Expenditures- As per World Bank data, global research and development expenditures contributed 2.63% to GDP in 2020. Compared to 2018, this represents a considerable increase from 2.2%.
• A Global Increase In Healthcare Spending- Approximately 19.7% of the nation's GDP was accounted for by healthcare expenditures in 2020, according to a report released by the Centers for Medicare & Medicaid Services. 
• Growing Incidence of Non Communicable Diseases- Worldwide, noncommunicable diseases (NCDs) cause 41 million deaths each year, accounting for 74% of all deaths. It is estimated that 17 million people die of a NCD before they reach 70 years of age every year; 86% of these premature deaths happen in countries with low and middle incomes.
• Global Increase In Geriatric Population- The World Bank recently reported that 747,238,580 people over 60 years of age lived worldwide at the end of 2021. Future projections predict a rise in the number.

Challenges

• Unapproval Of 3D Printed Drugs In Many Countries
• Drug Shortages Due To COVID-19 
• Inadequacies In Government Regulations Regarding 3D Printing